Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
VER 155008: Optimizing HSP 70 Inhibitor Workflows in Cancer
2026-06-13
VER 155008, a potent adenosine-derived HSP 70 inhibitor, enables precise control over apoptosis and cell proliferation assays in cancer research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and bridges the latest proteomic insights to experimental practice.
-
Eicosapentaenoic Acid: Optimized EPA Omega-3 Fatty Acid Work
2026-06-12
Eicosapentaenoic Acid (EPA) stands apart as a benchmark EPA omega-3 fatty acid for cardiovascular and immunology labs, delivering robust, reproducible outcomes in membrane modulation and lipid-lowering studies. This article translates recent mechanistic and workflow advances into hands-on, troubleshooting-oriented guidance to maximize assay impact.
-
Applied Protocols with 5,6-Dichloro-1-β-D-ribofuranosylbenzi
2026-06-12
Harness the translational power of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) to precisely modulate transcriptional elongation, enabling robust workflows from cell fate engineering to antiviral research. This guide distills experimental insights, reference breakthroughs, and practical troubleshooting for maximizing DRB’s impact in high-fidelity assays.
-
One-step TUNEL FITC Apoptosis Detection Kit: Precision in DN
2026-06-11
The One-step TUNEL FITC Apoptosis Detection Kit empowers researchers to detect apoptosis with high specificity in both cultured cells and tissue sections. Its streamlined protocol and robust FITC-labeled dUTP incorporation facilitate reproducible quantification across cancer, neurodevelopmental, and toxicology studies.
-
0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit
2026-06-11
0.4% Trypan Blue Solution offers a direct method for distinguishing live from dead cells in suspension, addressing the need for rapid, reproducible cell viability measurement in research workflows. It is best suited for standard cell counting and cytotoxicity assays, but not for clinical diagnostics or multiparametric applications requiring higher sensitivity or multiplexing.
-
STAT2 Coiled-Coil Degron Drives Zika Virus Interferon Evasio
2026-06-10
Parisien et al. elucidate how Zika virus NS5 targets a degron within the STAT2 coiled-coil domain for proteasomal degradation, thereby disabling interferon signaling. These findings clarify a key mechanism of viral immune evasion and offer new leads for therapeutic intervention.
-
TSPAN18 Stabilizes STIM1 to Drive Prostate Cancer Bone Metas
2026-06-10
Zhou et al. (2023) reveal that TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, promoting store-operated calcium entry (SOCE) and accelerating bone metastasis in prostate cancer. This mechanistic insight identifies potential molecular targets within the calcium signaling pathway for therapeutic intervention.
-
EZ Cap™ EPO mRNA (ψUTP): Advancing mRNA Stability & Neurorep
2026-06-09
Discover how EZ Cap™ EPO mRNA (ψUTP) unlocks next-generation human erythropoietin mRNA research through superior stability, capping, and translational efficiency. This in-depth analysis reveals unique mechanistic insights and strategic assay guidance beyond existing resources.
-
MEG3 Modulation of TGF-β1/PI3K/AKT in NiO NP-Induced Lung Fi
2026-06-09
The reference study uncovers how downregulation of lncRNA MEG3 contributes to pulmonary fibrosis following nickel oxide nanoparticle (NiO NP) exposure, acting via enhanced TGF-β1 expression and PI3K/AKT pathway activation. Importantly, the work demonstrates that the ALK5 inhibitor SB 431542 can suppress this profibrotic signaling, providing a mechanistic link and potential intervention strategy.
-
FAISL lncRNA Blocks FAK Proteolysis to Drive TNBC Progressio
2026-06-08
The reference study identifies the long noncoding RNA FAISL as a direct regulator of FAK protein stability in triple negative breast cancer (TNBC). By inhibiting Calpain 2-mediated FAK proteolysis, FAISL promotes tumor adhesion, proliferation, and metastasis, highlighting a novel mechanism and potential therapeutic target in aggressive breast cancer.
-
Epigenetic Dynamics and Vesicle Release in Shrimp Hemocyte I
2026-06-08
This study reveals that shrimp hemocytes exhibit rapid, dose-dependent histone modifications and extracellular vesicle release following priming with inactivated Vibrio parahaemolyticus. These findings establish a baseline for understanding epigenetic and vesicular mechanisms underlying innate immune regulation in crustaceans, offering new directions for disease resilience research in aquaculture.
-
Cisplatin (CDDP): Mechanistic Depth and Emerging Research Fr
2026-06-07
Explore the advanced mechanistic roles of Cisplatin (CDDP) in cancer research, with a focus on DNA crosslinking, apoptosis pathways, and new insights into RNA methylation and DNA repair. This article extends beyond conventional discussions to inform experimental design and chemoresistance studies.
-
S-Adenosylmethionine in CNS Methylation: Protocols and Pitfa
2026-06-06
Harness S-adenosylmethionine (Ademetionine) to drive precision in methylation assays, epigenetic studies, and central nervous system disorder models. This article delivers actionable experimental protocols, troubleshooting strategies, and translational insights grounded in data-rich literature and product expertise.
-
Bergenin Targets γδT17 Cells in Psoriasis via PPARγ-PROX1 Ax
2026-06-05
This study uncovers how bergenin, a natural PPARγ agonist from Bergenia purpurascens, selectively suppresses pathogenic γδT17 cells to ameliorate psoriasis. By elucidating a PPARγ-mediated mechanism that degrades PROX1 and inhibits IL-17A production, the findings advance our understanding of metabolic and transcriptional control in psoriatic inflammation.
-
Zoledronic Acid: Optimizing Cancer Cell Apoptosis & Bone Dis
2026-06-05
Zoledronic Acid, a nitrogen-containing bisphosphonate, empowers research on cancer cell apoptosis and bone disease prevention through rigorously validated protocols. Explore advanced use-cases, stepwise workflows, and actionable troubleshooting tips to maximize experimental reliability and translational insight.